Central blockade of salusin β attenuates hypertension and hypothalamic inflammation in spontaneously hypertensive rats

Sci Rep. 2015 Jul 29:5:11162. doi: 10.1038/srep11162.

Abstract

Salusin β is a multifunctional bioactive peptide and is considered as a promising candidate biomarker for predicting atherosclerotic cardiovascular diseases. The present study was designed to investigate the roles and mechanisms of salusin β in the paraventricular nucleus (PVN) in attenuating hypertension and hypothalamic inflammation and whether central salusin β blockade has protective effects in essential hypertension. Normotensive Wistar-Kyoto (WKY) rats and spontaneously hypertensive rats (SHR) were used in this study. The rats were chronic PVN infusion either specific salusin β blocker, antisalusin β IgG (SIgG), or control IgG (CIgG) for 2 weeks. Hypertensive rats had significantly increased salusin β expression compared with normotensive rats. Central blockade of salusin β attenuated hypertension, reduced circulating norepinephrine (NE) levels, and improved cardiac hypertrophy and function in hypertensive rats. Salusin β blockade significantly reduced proinflammatory cytokines (PICs), nuclear factor-kappa B (NF-κB) activity, reactive oxygen species (ROS) levels, and altered renin-angiotensin system (RAS) components in the PVN of hypertensive rats. These findings suggest that the beneficial effects of salusin β blockade in essential hypertension are possibly due to down-regulate of inflammatory molecules and ROS in the PVN.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Monoclonal / pharmacology
  • Blood Pressure / drug effects
  • Cardiomegaly / diagnosis
  • Cardiomegaly / drug therapy
  • Cardiomegaly / etiology
  • Cytokines / metabolism
  • Essential Hypertension
  • Heart Rate / drug effects
  • Hypertension / etiology*
  • Hypertension / metabolism*
  • Hypertension / physiopathology
  • Hypothalamus / drug effects
  • Hypothalamus / metabolism*
  • Hypothalamus / pathology
  • Immunoglobulin G / pharmacology
  • Inflammation / drug therapy
  • Inflammation / metabolism*
  • Inflammation Mediators / metabolism
  • Intercellular Signaling Peptides and Proteins / metabolism*
  • Male
  • Membrane Glycoproteins / genetics
  • Membrane Glycoproteins / metabolism
  • NADPH Oxidase 2
  • NADPH Oxidases / genetics
  • NADPH Oxidases / metabolism
  • NF-kappa B / metabolism
  • Oxidative Stress / drug effects
  • Paraventricular Hypothalamic Nucleus / drug effects
  • Paraventricular Hypothalamic Nucleus / metabolism
  • Peptidyl-Dipeptidase A / genetics
  • Peptidyl-Dipeptidase A / metabolism
  • Rats
  • Rats, Inbred SHR
  • Reactive Oxygen Species / metabolism

Substances

  • Antibodies, Monoclonal
  • Cytokines
  • Immunoglobulin G
  • Inflammation Mediators
  • Intercellular Signaling Peptides and Proteins
  • Membrane Glycoproteins
  • NF-kappa B
  • Reactive Oxygen Species
  • salusin-beta, rat
  • Cybb protein, rat
  • NADPH Oxidase 2
  • NADPH Oxidases
  • Peptidyl-Dipeptidase A